Billig N
Geriatric Psychiatry Program, Georgetown University Medical Center, Washington, DC 20007, USA.
Drugs Aging. 1996 Aug;9(2):93-100. doi: 10.2165/00002512-199609020-00004.
Agitation in demented nursing home residents is a major clinical problem with which patients, families and staff are required to cope. Agitation may be secondary to a variety of psychiatric, environmental and medical problems, and thus attempts must be made to [correction of be] clarify aetiological issues before initiating a treatment plan. Treatments for agitation are imperfect, and clinicians should be prepared to work through several to find the best for a given patient and clinical situation. Cognitive/behavioural/environmental treatments have the advantage of few or no adverse effects and no drug-drug interactions. Some of these define rather basic nursing management techniques for coping with agitated older adults, while others attempt to diminish specific behaviours. The use of pharmacological interventions should be reserved for those patients in whom other measures have been unsuccessful. While the range of medications that have been used to treat various kinds of agitated behaviours is large, there are few double-blind, placebo-controlled trials in this area and fewer still in nursing home populations. No one class and no one medication has been identified as a treatment of choice. While we work to find the aetiological mechanisms of irreversible forms of dementia, and the possible treatments for the underlying disorders, the challenge to develop more effective medications with better adverse effect profiles is before us.
痴呆养老院患者的激越行为是患者、家属和工作人员都需要应对的一个主要临床问题。激越可能继发于多种精神、环境和医学问题,因此在启动治疗方案之前,必须努力明确病因问题。针对激越的治疗并不完善,临床医生应准备好尝试多种方法,为特定患者和临床情况找到最佳治疗方案。认知/行为/环境治疗的优点是不良反应很少或没有,也不存在药物相互作用。其中一些方法定义了应对激越老年人的相当基本的护理管理技巧,而其他一些方法则试图减少特定行为。药物干预应仅用于其他措施均未成功的患者。虽然用于治疗各种激越行为的药物种类繁多,但该领域几乎没有双盲、安慰剂对照试验,在养老院人群中的此类试验更少。尚未确定哪一类药物或哪一种药物是首选治疗药物。在我们努力寻找不可逆性痴呆的病因机制以及潜在疾病的可能治疗方法的同时,开发具有更好不良反应谱的更有效药物的挑战摆在我们面前。